ライフサイエンスコーパス: transcription elongation factor

1 d us to propose that TEFM is a mitochondrial transcription elongation factor.

2 skipping, resulting from the actions of ELL2 transcription elongation factor.

3 These results define Ssu72 as a transcription elongation factor.

4 the foggy/spt5 locus, which encodes another transcription elongation factor.

5 ncodes a protein similar to Spt6, a proposed transcription elongation factor.

6 that the A18R protein may act as a negative transcription elongation factor.

7 scription is dependent on the Spt6 and Spt16 transcription elongation factors.

8 etically with a number of known or suspected transcription elongation factors.

9 de concentrations or the inhibition of other transcription elongation factors.

10 on elongation factor b (P-TEFb) and negative transcription elongation factors, 5,6-dichloro-1-beta-d-

11 sitol polyphosphate phosphohydrolase family, Transcription Elongation Factor A family, LDOC1-related

12 2 (E2f2) and Brain Expressed X-Linked (Bex)/Transcription elongation factor A-like (Tceal) superfami

13 shown that a frequently downregulated gene, transcription elongation factor A-like 7 (TCEAL7), promo

14 In order to identify previously unknown transcription elongation factors, a genetic screen was c

15 BRDs, the Mediator complex and the positive transcription elongation factor (Abstract figure).

16 ression through the regulated binding of the transcription elongation factor AFF3 between a DMR and a

17 We conclude that transcription elongation factors alleviate fundamental c

18 We showed recently that Spt6, a transcription elongation factor and histone H3 chaperone

19 RNAPII but constitutively evicts Spt5, a key transcription elongation factor and TC-NER repressor, fr

20 binding complex (CBC) directs recruitment of transcription elongation factors and establishes proper

21 that Nap1 genetically interacts with several transcription elongation factors and that both Nap1 and

22 Spt5, a transcription elongation factor, and Rpb4, a subunit of

23 s protein was previously shown to be a viral transcription elongation factor, and the present finding

24 2Delta double mutants (PPR2 encodes TFIIS, a transcription elongation factor) are synthetically hyper

25 Here, we identify TFIIS.h, a transcription elongation factor, as a new transcriptiona

26 Transcription elongation factors associate with RNA poly

27 The positive transcription elongation factor b (P-TEFb) (CDK9/cyclin

28 present evidence that Tax recruits positive transcription elongation factor b (P-TEFb) (CDK9/cyclin

29 ified a blockade in the specialized positive transcription elongation factor b (P-TEFb) activation me

30 ld be rescued by additional loss of positive transcription elongation factor b (P-TEFb) activity, a k

31 romodomain protein 4 (BRD4) and the positive transcription elongation factor b (P-TEFb) and facilitat

32 lay between the recently discovered positive transcription elongation factor b (P-TEFb) and negative

33 lay between the recently identified positive transcription elongation factor b (P-TEFb) and negative

34 cyclin T1 (hCycT1) protein from the positive transcription elongation factor b (P-TEFb) binds the tra

35 1 was recently shown to inhibit the positive transcription elongation factor b (P-TEFb) by interactin

36 CDKC;2 functions in an Arabidopsis positive transcription elongation factor b (P-TEFb) complex and i

37 1), the inhibitory component of the positive transcription elongation factor b (P-TEFb) complex, as a

38 which together with CDK9 forms the positive transcription elongation factor b (P-TEFb) complex, Tat

39 Different positive transcription elongation factor b (P-TEFb) complexes iso

40 Positive transcription elongation factor b (P-TEFb) complexes, co

41 ing cyclin T partners belong to the positive transcription elongation factor b (P-TEFb) complexes, wh

42 The positive transcription elongation factor b (P-TEFb) contains cycl

43 Positive transcription elongation factor b (P-TEFb) controls the

44 ome genes has also been shown to be positive transcription elongation factor b (P-TEFb) dependent.

45 ator of paused Pol II release, that positive transcription elongation factor b (P-TEFb) directly regu

46 The positive transcription elongation factor b (P-TEFb) exists in two

47 pisomal plasmids also released free positive transcription elongation factor b (P-TEFb) from its inhi

48 DX21 facilitates the release of the positive transcription elongation factor b (P-TEFb) from the 7SK

49 Inhibition of positive transcription elongation factor b (P-TEFb) had only a mo

50 Positive transcription elongation factor b (P-TEFb) hyperphosphor

51 ymerase II (Pol II) is regulated by positive transcription elongation factor b (P-TEFb) in associatio

52 do not find evidence for a role of positive transcription elongation factor b (P-TEFb) in the establ

53 t (transactivator of transcription)-positive transcription elongation factor b (P-TEFb) interaction a

54 ation, in particular members of the positive transcription elongation factor b (P-TEFb) involved in t

55 The positive transcription elongation factor b (P-TEFb) is a cyclin-d

56 The positive transcription elongation factor b (P-TEFb) is a key cell

57 Positive transcription elongation factor b (P-TEFb) is a kinase t

58 The positive transcription elongation factor b (P-TEFb) is involved i

59 al domain of RNA polymerase II, the positive transcription elongation factor b (P-TEFb) is the critic

60 Positive transcription elongation factor b (P-TEFb) is the major

61 functions as a positive regulator of Pol II transcription elongation factor b (P-TEFb) kinase and, i

62 lthough the level of binding of the positive transcription elongation factor b (P-TEFb) kinase was no

63 ion elongation is stimulated by the positive transcription elongation factor b (P-TEFb) kinase, which

64 zed as the catalytic subunit of the positive transcription elongation factor b (P-TEFb) of RNA polyme

65 Human positive transcription elongation factor b (P-TEFb) phosphorylate

66 The Positive Transcription Elongation Factor b (P-TEFb) phosphorylate

67 tion of transcription elongation by positive transcription elongation factor b (P-TEFb) plays a centr

68 Positive transcription elongation factor b (P-TEFb) plays an impo

69 The positive transcription elongation factor b (P-TEFb) promotes tran

70 nt and sustained HIV elongation and positive transcription elongation factor b (P-TEFb) recruitment a

71 Positive transcription elongation factor b (P-TEFb) regulates euk

72 The positive transcription elongation factor b (P-TEFb) regulates RNA

73 Among others, it recruits positive transcription elongation factor b (P-TEFb) to MHC class

74 virally encoded Tat protein hijacks positive transcription elongation factor b (P-TEFb) to phosphoryl

75 In host cells, Brd4 recruits positive transcription elongation factor b (P-TEFb) to stimulate

76 the cyclin T1 (CycT1) component of positive transcription elongation factor b (P-TEFb) to TAR.

77 rotein-associated factor (PCAF) and positive transcription elongation factor b (P-TEFb) to Tat/transa

78 Tat-dependent recruitment of human positive transcription elongation factor b (P-TEFb) to the HIV-1

79 the transactivator Tat recruits the positive transcription elongation factor b (P-TEFb) to the initia

80 type 1 (HIV-1) Tat protein recruits positive transcription elongation factor b (P-TEFb) to the transa

81 l transactivator (Tat) recruits the positive transcription elongation factor b (P-TEFb) to the viral

82 Tat protein requires recruitment of positive transcription elongation factor b (P-TEFb) to the viral

83 es cell viability by activating the positive transcription elongation factor b (P-TEFb) via its relea

84 hat phospho-Ser(276) RelA binds the positive transcription elongation factor b (P-TEFb), a complex co

85 Positive transcription elongation factor b (P-TEFb), a complex of

86 RNP) sequesters and inactivates the positive transcription elongation factor b (P-TEFb), an essential

87 AIRE, increases its binding to the positive transcription elongation factor b (P-TEFb), and potentia

88 The positive transcription elongation factor b (P-TEFb), composed of

89 The positive transcription elongation factor b (P-TEFb), composed of

90 Positive transcription elongation factor b (P-TEFb), composed of

91 The kinase activity of positive transcription elongation factor b (P-TEFb), composed of

92 The positive transcription elongation factor b (P-TEFb), comprised of

93 The positive transcription elongation factor b (P-TEFb), comprising C

94 The cellular positive transcription elongation factor b (P-TEFb), containing c

95 general elongation factors are the positive transcription elongation factor b (P-TEFb), eleven-ninet

96 Tat and its cellular cofactor, the positive transcription elongation factor b (P-TEFb), overcome thi

97 The CDK9-cyclin T kinase complex, positive transcription elongation factor b (P-TEFb), stimulates t

98 ase II kinase and elongation factor positive transcription elongation factor b (P-TEFb), the complex

99 hat RBPJ binds CDK9, a component of positive transcription elongation factor b (P-TEFb), to target ge

100 ase II (RNAPII) is regulated by the positive transcription elongation factor b (P-TEFb), which contai

101 ng between a prototypic AAD and the positive transcription elongation factor b (P-TEFb), which contai

102 main of RNA polymerase II (RNAPII), positive transcription elongation factor b (P-TEFb), which is com

103 ) is best known as the inhibitor of positive transcription elongation factor b (P-TEFb), which regula

104 e H3-K79 methyltransferase DOT1 and positive transcription elongation factor b (P-TEFb).

105 f transcription factor (TF) IIH and positive transcription elongation factor b (P-TEFb).

106 plex is critically dependent on the positive transcription elongation factor b (P-TEFb).

107 erase II elongation factor known as positive transcription elongation factor b (P-TEFb).

108 nal interaction between ERalpha and positive transcription elongation factor b (P-TEFb).

109 the animal CDK9-CycT complex of the positive transcription elongation factor b (P-TEFb).

110 iates its specific interaction with positive transcription elongation factor b (P-TEFb).

111 plexes, referred to collectively as positive transcription elongation factor b (P-TEFb).

112 inT1 and Cdk9 that constitutes core positive transcription elongation factor b (P-TEFb).

113 by RNA polymerase II depends on the positive transcription elongation factor b (P-TEFb).

114 requires the kinase activity of the positive transcription elongation factor b (P-TEFb).

115 nding of Tat to the cellular kinase positive transcription elongation factor b (P-TEFb).

116 transcription via the inhibition of positive transcription elongation factor b (P-TEFb).

117 ucturally and functionally from the positive transcription elongation factor b (P-TEFb).

118 ator Tat and its cellular cofactor, positive transcription elongation factor b (P-TEFb).

119 ase II (RNAPII) is regulated by the positive transcription elongation factor b (P-TEFb).

120 l replication through inhibition of positive transcription elongation factor b (P-TEFb).

121 controlling the nuclear activity of positive transcription elongation factor b (P-TEFb).

122 pendent kinases CDK13 and CDK11 and positive transcription elongation factor b (P-TEFb).

123 iption elongation by inhibiting the positive transcription elongation factor b (P-TEFb, a complex of

124 uppressor through the inhibition of positive transcription elongation factor b (P-TEFb; CDK9/cyclin T

125 ich motif (ARM) to recruit the host positive transcription elongation factor b (pTEFb) complex onto t

126 its previously reported effects on positive transcription elongation factor b and HMBA inducible pro

127 transcriptional complex comprising positive transcription elongation factor b and RNA polymerase II.

128 se and the catalytic subunit of the positive-transcription elongation factor b and the Tat-activating

129 interactions with both 7SK RNA and positive transcription elongation factor b are critical for HEXIM

130 ogether with CDK9, the component of positive transcription elongation factor b complex responsible fo

131 stablishment of Pol II pausing, and positive transcription elongation factor b releases (P-TEFb) paus

132 domain and increased recruitment of positive transcription elongation factor b to the LTR promoter.

133 egulate transcription by recruiting Positive Transcription Elongation Factor b to the promoter region

134 t strategies to recruit Tat and the positive transcription elongation factor b to their promoters, an

135 itional BRD4 and associated P-TEFB (positive transcription elongation factor b) complexes in the tran

136 P-TEFb (positive transcription elongation factor b) inhibitors such as fl

137 ed for interaction with the P-TEFb (positive transcription elongation factor b) kinase complex and fo

138 pendent of the reduction of P-TEFb (positive transcription elongation factor b) levels caused by NF90

139 nsitivity-Inducing Factor), P-TEFb (Positive Transcription Elongation Factor b), TFIIH, TFIIF, and FA

140 (CCNT2), the regulatory subunit of positive transcription elongation factor b, a complex that inhibi

141 kinase heterodimer that constitutes positive transcription elongation factor b, is a well-validated t

142 ed, cdk-9, the catalytic subunit of positive transcription elongation factor b, was significantly dow

143 nd BD2 and forms a complex with the positive transcription elongation factor b, which controls phosph

144 domain-containing protein 4 and the positive transcription elongation factor b.

145 op structure and recruitment of the positive transcription elongation factor b.

146 both Tat and the essential cellular cofactor transcription elongation factor-b (P-TEFb) by binding si

147 n and apoptosis was mimicked by the positive transcription elongation factor-b (P-TEFb) inhibitor DRB

148 longation by recruiting the P-TEFb (positive transcription elongation factor-b) (CycT1:CDK9) C-termin

149 nd of the elongation factor P-TEFb (positive transcription elongation factor-b), which consists minim

150 phorylation of RNA polymerase II by positive transcription elongation factor-b, leading to a block in

151 (CDK9), the catalytic component of positive transcription elongation factor-b, phosphorylates serine

152 Cyclin T1 (CycT1), a component of positive-transcription-elongation factor-b (P-TEFb), is an essent

153 This general transcription elongation factor binds to RNA polymerase

154 ve elongation factor (NELF), act as negative transcription elongation factors by increasing the time

155 variety of eukaryotic proteins including the transcription elongation factor CA150, the splicing fact

156 e of the first three FF domains of the human transcription elongation factor CA150.

157 r TEAD4, coactivators BRD4 and MED1, and the transcription elongation factor CDK9 for transcription.

158 he cyclin T1 (CycT1) subunit of the positive transcription elongation factor complex (P-TEFb).

159 he cyclin T1 (CycT1) subunit of the positive transcription elongation factor complex b (P-TEFb).

160 he cyclin T1 (CycT1) subunit of the positive transcription elongation factor complex, P-TEFb.

161 lysine-rich leukemia gene)/P-TEFb (positive transcription elongation factor)-containing super elonga

162 Transcription elongation factors dramatically affect RNA

163 system, we characterized the association of transcription elongation factor DSIF with RNAP II elonga

164 on elongation factor b (P-TEFb) and negative transcription elongation factors, DSIF (5, 6-dichloro-1-

165 The transcription elongation factor eleven nineteen lysine-r

166 elongation complex (LEC)-which contains the transcription elongation factor ELL/EAF-was found to be

167 disordered scaffold proteins AFF1/4 and the transcription elongation factors ELL1/2 are core compone

168 hat both the splicing factor hnRNPLL and the transcription elongation factor ELL2 modulate the ratio

169 The RNA polymerase II transcription elongation factor ELL2, which is induced i

170 d form by activating Ell2 (which encodes the transcription-elongation factor ELL2).

171 EPOP interacts with the transcription elongation factor Elongin BC and the H2B d

172 The RNA polymerase II (Pol II) transcription elongation factor, Elongin A (EloA), is me

173 Spt4-Spt5, a general transcription elongation factor for RNA polymerase II, a

174 Transcription elongation factors from the NusG family ar

175 RFA1 interacts genetically with transcription elongation factor genes.

176 Transcription elongation factor GreA efficiently blocked

177 Transcription elongation factor GreA induces nucleolytic

178 ymerase (RNAP) secondary channel such as the transcription elongation factors GreA and GreB in E. col

179 Bacterial transcription elongation factors GreA and GreB stimulate

180 Prokaryotic transcription elongation factors GreA and GreB stimulate

181 role in LPS synthesis, including a possible transcription elongation factor (GreA), a possible queui

182 drogenase, thioredoxin peroxidase, catalase, transcription elongation factor) had C-terminal lysine r

183 plex with Rpb7, and the Spt4-Spt5 complex, a transcription elongation factor, have been shown to supp

184 d that, in this circumstance, DksA acts as a transcription elongation factor in vivo.

185 ts suggest that Rtf1 may function as a novel transcription elongation factor in yeast.

186 ism for the cooperative function of distinct transcription elongation factors in chromatin transcript

187 en spt2Delta and mutations in genes encoding transcription elongation factors, including members of t

188 transcriptional checkpoint, whereby negative transcription elongation factors induce an elongation bl

189 SDG8, directly or indirectly through IWS1, a transcription elongation factor involved in BR-regulated

190 This universally conserved transcription elongation factor is known as Spt5 in arch

191 and in the presence and absence of TFIIS, a transcription elongation factor known to increase transc

192 gion of the rtfA gene, encoding a RNA-pol II transcription elongation factor-like protein, similar to

193 c bypass rate, which is exacerbated by TEFM (transcription elongation factor mitochondrial).

194 ain of Pol II-and enrichment of the positive transcription elongation factors MYC, BRD4, PAF1, and th

195 (TAR) element, RD protein from the negative transcription elongation factor (NELF) inhibits basal tr

196 e both previously characterized genes (e.g., transcription elongation factor NusA and tumor necrosis

197 The universal bacterial transcription elongation factor NusA mediates elongation

198 We report observations suggesting that the transcription elongation factor NusA promotes a previous

199 the glyQS leader and the effect of tRNA and transcription elongation factors NusA and NusG on transc

200 rmination factor Rho and the requirement for transcription elongation factors NusA and NusG was inves

201 The bacterial transcription elongation factor, NusA, functions as an a

202 The transcription elongation factor NusG facilitates this te

203 l similarity to the Tudor-like domain of the transcription elongation factor NusG plays a critical ro

204 The bacterial transcription elongation factor NusG stimulates the Rho-

205 d termination, it is fully responsive to the transcription elongation factor NusG.

206 Transcription elongation factor NusG/Spt5 spans the cent

207 RNA polymerase (RNAP), the ribosome, and the transcription elongation factors NusG and NusA.

208 Here we show that c17orf42, hereafter TEFM (transcription elongation factor of mitochondria), makes

209 The metazoan transcription elongation factor P-TEFb (CDK-9/cyclin T)

210 oteins LARP7 and MePCE captures the positive transcription elongation factor P-TEFb and prevents phos

211 In contrast, the positive transcription elongation factor P-TEFb is a local explor

212 The human positive transcription elongation factor P-TEFb is composed of tw

213 with the kinase CDK9, is a component of the transcription elongation factor P-TEFb which binds the h

214 erases are poised to respond to the positive transcription elongation factor P-TEFb, and then enter p

215 The human positive transcription elongation factor P-TEFb, consisting of a

216 ption elongation by recruitment of the human transcription elongation factor P-TEFb, consisting of CD

217 ional elongation by recruitment of the human transcription elongation factor P-TEFb, consisting of Cd

218 associate with AFF4, ELLs, and the positive transcription elongation factor P-TEFb, providing eviden

219 of HIV-1 transcription is mediated by human transcription elongation factor P-TEFb, which interacts

220 2nd pause region is independent of positive transcription elongation factor P-TEFb.

221 ry subunit of CDK9 and as a component of the transcription elongation factor P-TEFb.

222 se II, via its interaction with the positive transcription elongation factor P-TEFb.

223 e illustrates the importance of the positive transcription elongation factor (P-TEF)b in control of g

224 t ligand-activated AhR recruits the positive transcription elongation factor (P-TEFb) and RNA polymer

225 a regulatory partner of CDK9 in the positive transcription elongation factor (P-TEFb) complex, and bi

226 cyclinT1 (hCyclinT1) subunit of the positive transcription elongation factor (P-TEFb) complex, which

227 Both screens revealed roles for the positive transcription elongation factor (P-TEFb) component Cycli

228 The positive transcription elongation factor (P-TEFb) is required for

229 myocytes by elevating levels of the positive transcription elongation factor (P-TEFb), instating a la

230 Positive transcription elongation factor (P-TEFb), which is compo

231 hinery through interaction with the positive transcription elongation factor, P-TEFb, and directs the

232 The positive transcription elongation factor, P-TEFb, controls the fr

233 sed and requires Tat to recruit the positive transcription elongation factor, P-TEFb, which functions

234 combination with deletions in genes encoding transcription elongation factors; p53 likewise confers h

235 irus (HIV-1) by recruiting the host positive transcription elongation factor (pTEFb) to the RNA polym

236 traightforward as temporary backtracking and transcription elongation factor S-II (TFIIS)-dependent R

237 N-terminal bromo-adjacent homology (BAH) and transcription elongation factor S-II (TFS2N) domains and

238 Transcription elongation factor SII (TFIIS) assists RNA

239 The transcription elongation factor SII is a major component

240 is homologous to a domain in the eukaryotic transcription elongation factor SII.

241 s, in a pattern similar to that observed for transcription elongation factor Spt16p.

242 We found that targeting the transcription elongation factor Spt4 selectively decreas

243 teraction sites of the TFE WH domain and the transcription elongation factor Spt4/5 overlap, and both

244 ow TFIIH occupancy and high occupancy of the transcription elongation factor Spt4/Spt5 suppresses TC-

245 between three classes of these factors: (1) transcription elongation factors Spt4-Spt5, TFIIS, and S

246 KTF1 has similarity to the transcription elongation factor SPT5 and contains a C-te

247 The transcription elongation factor Spt5 is conserved from b

248 rboxyl-terminal domain (CTD) of the S. pombe transcription elongation factor Spt5, which consists of

249 l interaction between Rtf1 and the essential transcription elongation factor Spt5.

250 s the pol II C-terminal domain (CTD) and the transcription elongation factor Spt5.

251 protein that is structurally related to the transcription elongation factor Spt5.

252 P II) carboxyl-terminal domain (CTD) and the transcription elongation factors SPT5 and Tat-SF1 in a T

253 de new evidence for a connection between the transcription elongation factor Spt6 and 3'-end formatio

254 The transcription elongation factor Spt6 and the H3K36 methy

255 e demonstrate that the histone chaperone and transcription elongation factor Spt6 spatially and tempo

256 dition to serving as a histone chaperone and transcription elongation factor, Spt6 counteracts repres

257 elongation complex (SEC) that includes known transcription elongation factors such as eleven-nineteen

258 cts early elongation complexes from negative transcription elongation factors such as NELF, DSIF, and

259 We showed previously that transcription elongation factors such as SKIP are dispen

260 sful, and the essentiality of both conserved transcription elongation factors suggests that both cons

261 We identified the transcription elongation factor suppressor of Ty 6 (Spt6

262 rt in Science that targeted reduction in the transcription elongation factor SUPT4H1/SUPT5H reduces b

263 tep, we designed sequence-specific synthetic transcription elongation factors (Syn-TEFs).

264 of the C-terminal region of cyclin T1 to the transcription elongation factor Tat-SF1 and perhaps othe

265 onucleoproteins (snRNPs) interact with human transcription elongation factor TAT-SF1 and strongly sti

266 We found that interaction of human transcription elongation factor TEFM with mitochondrial

267 which we here show to be independent of the transcription elongation factor TEFM.

268 ate of nascent transcripts is coordinated by transcription elongation factors (TEFs) such as polymera

269 ns and cyclin K generating distinct Positive-Transcription Elongation Factors termed P-TEFb.

270 Here, we used a mutant version of the transcription elongation factor TFIIS (TFIIS(mut)), aimi

271 The three structural domains of transcription elongation factor TFIIS are conserved from

272 t evidence that the evolutionarily conserved transcription elongation factor TFIIS functions during p

273 domain resembling the central domain in the transcription elongation factor TFIIS.

274 Previously, it was shown that transcription elongation factors TFIIS and Cockayne's sy

275 ing study of the interactions of RNAPII with transcription elongation factors TFIIS and TFIIF, which

276 NusG/Spt5 is a transcription elongation factor that assists in DNA-temp

277 protein is a universally conserved bacterial transcription elongation factor that binds RNA polymeras

278 ucing factor (DSIF or Spt4/5) is a conserved transcription elongation factor that both inhibits and s

279 Our results establish UvrD as a bona fide transcription elongation factor that contributes to geno

280 Spt4, a transcription elongation factor that forms a complex wit

281 spt6 encodes a transcription elongation factor that genetically interac

282 TFIIS is a transcription elongation factor that has been extensivel

283 ven-nineteen lysine rich leukemia gene, is a transcription elongation factor that is induced approxim

284 composed of Cdk9 and cyclin T1, is a general transcription elongation factor that phosphorylates the

285 NusA and NusG are transcription elongation factors that bind to RNA polyme

286 t directly engage and remodel nucleosomes or transcription elongation factors that facilitate Pol II

287 SII proteins of eukaryotes and archaea, are transcription elongation factors that promote an endogen

288 The vast majority of organisms possess transcription elongation factors, the functionally simil

289 We found unexpectedly that, similar to known transcription elongation factors, these and several othe

290 ylation-independent interaction of Npl3 with transcription elongation factor Tho2 and inhibited Npl3

291 horylates RNA polymerase II and the negative transcription elongation factor to stimulate the elongat

292 tion factors, histone-modifying enzymes, and transcription elongation factors to activate BR-induced

293 complexes, histone-modification enzymes and transcription elongation factors to aid transcription th

294 erases, bromodomain-containing proteins, and transcription elongation factors to mediate chromatin re

295 acetylation, and tethers chromatin modifiers/transcription elongation factors to target genes.

296 ipitation demonstrated that NELF, a negative transcription elongation factor, was associated with the

297 a recruitment of the cyclin T1/CDK9 positive transcription elongation factor, which phosphorylates th

298 nscription) has long been considered to be a transcription elongation factor whose ability to destabi

299 Paf1 complex (Paf1C) is a transcription elongation factor whose recruitment is sti

300 ase-associated factor 1 complex (Paf1C) is a transcription elongation factor with known roles in Pol